topspin medical - MYSZ

MYSZ

Close Chg Chg %
4.17 0.05 1.20%

Closed Market

4.22

+0.05 (1.20%)

Volume: 439.90K

Last Updated:

Dec 26, 2024, 4:00 PM EDT

Company Overview: topspin medical - MYSZ

MYSZ Key Data

Open

$3.98

Day Range

3.87 - 4.42

52 Week Range

1.05 - 7.94

Market Cap

$2.67M

Shares Outstanding

641.46K

Public Float

574.35K

Beta

0.93

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$20.48

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

6.34M

 

MYSZ Performance

1 Week
 
-0.71%
 
1 Month
 
227.13%
 
3 Months
 
149.70%
 
1 Year
 
-21.85%
 
5 Years
 
-99.37%
 

MYSZ Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About topspin medical - MYSZ

My Size, Inc. engages in the development of measurement technologies. It provides solutions for e-commerce, apparel, shipping and parcel delivery, and do-it-yourself industry applications. The firm offers measurement apps including MySizeID, BoxSize, and SizeUP. The company was founded by Ronen Luzon on September 20, 1999 and is headquartered in Airport City, Israel.

MYSZ At a Glance

My Size, Inc.
4 Hayarden Street
Airport City, HaMerkaz 70100
Phone 972-3-600-9030 Revenue 7.00M
Industry Internet Software/Services Net Income -6,380,000.00
Sector Technology Services 2023 Sales Growth 56.896%
Fiscal Year-end 12 / 2024 Employees 25
View SEC Filings

MYSZ Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA N/A
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

MYSZ Efficiency

Revenue/Employee 279,840.00
Income Per Employee -255,200.00
Receivables Turnover 5.825
Total Asset Turnover 0.737

MYSZ Liquidity

Current Ratio 1.709
Quick Ratio 0.966
Cash Ratio 0.584

MYSZ Profitability

Gross Margin 39.037
Operating Margin -86.764
Pretax Margin -95.955
Net Margin -91.195
Return on Assets -67.193
Return on Equity -137.633
Return on Total Capital -117.517
Return on Invested Capital -123.488

MYSZ Capital Structure

Total Debt to Total Equity 14.657
Total Debt to Total Capital 12.783
Total Debt to Total Assets 7.492
Long-Term Debt to Equity 7.983
Long-Term Debt to Total Capital 6.963
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Topspin Medical - MYSZ

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
142.00K 131.00K 4.46M 7.00M
Sales Growth
+125.40% -7.75% +3,303.82% +56.90%
Cost of Goods Sold (COGS) incl D&A
- 84.00K 4.15M 4.27M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
82.00K 85.00K 328.00K 466.00K
Depreciation
82.00K 85.00K 173.00K 164.00K
Amortization of Intangibles
- - 155.00K 302.00K
-
COGS Growth
- - +64.71% +2.70%
-
Gross Income
- 58.00K 306.00K 2.73M
Gross Income Growth
- - +383.33% +792.48%
-
Gross Profit Margin
- +40.85% +6.86% +39.04%
2020 2021 2022 2023 5-year trend
SG&A Expense
6.20M 10.62M 8.42M 8.80M
Research & Development
1.52M 4.25M 1.70M 974.00K
Other SG&A
4.68M 6.38M 6.72M 7.83M
SGA Growth
+3.37% +71.23% -20.78% +4.57%
Other Operating Expense
- - - -
-
Unusual Expense
- (33.00K) (56.00K) 671.00K
EBIT after Unusual Expense
(6.11M) (10.52M) (8.11M) (6.74M)
Non Operating Income/Expense
- (37.00K) 1.00K 28.00K
Non-Operating Interest Income
- - - 99.00K
-
Equity in Earnings of Affiliates
- - - (71.00K)
-
Interest Expense
- - 7.00K 236.00K
-
Interest Expense Growth
- - +133.33% -100.00%
-
Gross Interest Expense
- - 7.00K 236.00K
-
Interest Capitalized
- - - -
-
Pretax Income
(6.16M) (10.52M) (8.35M) (6.71M)
Pretax Income Growth
-12.01% -70.86% +20.67% +19.57%
Pretax Margin
-4,335.92% -8,030.53% -187.17% -95.95%
Income Tax
- - (36.00K) (333.00K)
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - (71.00K)
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(6.16M) (10.52M) (8.31M) (6.38M)
Minority Interest Expense
- - - -
-
Net Income
(6.16M) (10.52M) (8.31M) (6.38M)
Net Income Growth
-12.01% -70.86% +21.01% +23.23%
Net Margin Growth
-4,335.92% -8,030.53% -186.36% -91.19%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(6.16M) (10.52M) (8.31M) (6.38M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(6.16M) (10.52M) (8.31M) (6.38M)
EPS (Basic)
-222.286 -200.198 -59.7889 -20.0096
EPS (Basic) Growth
+59.58% +9.94% +70.14% +66.53%
Basic Shares Outstanding
27.70K 52.55K 138.99K 318.85K
EPS (Diluted)
-222.286 -200.198 -59.7889 -20.0096
EPS (Diluted) Growth
+59.58% +9.94% +70.14% +66.53%
Diluted Shares Outstanding
27.70K 52.55K 138.99K 318.85K
EBITDA
(6.06M) (10.49M) (7.78M) (5.60M)
EBITDA Growth
-1.74% -73.02% +25.83% +27.99%
EBITDA Margin
-4,270.42% -8,009.16% -174.52% -80.10%

Snapshot

Average Recommendation BUY Average Target Price 5.00
Number of Ratings 1 Current Quarters Estimate -0.65
FY Report Date 12 / 2024 Current Year's Estimate -4.04
Last Quarter’s Earnings -1.25 Median PE on CY Estimate N/A
Year Ago Earnings -20.43 Next Fiscal Year Estimate -2.70
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 N/A 1 1
Mean Estimate -0.65 N/A -4.04 -2.70
High Estimates -0.65 N/A -4.04 -2.70
Low Estimate -0.65 N/A -4.04 -2.70
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Topspin Medical in the News